Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Durosinmi, MA"'
Publikováno v:
Vascular Health and Risk Management, Vol Volume 18, Pp 27-42 (2022)
Abayomi O Bamgboje,1 Muheez A Durosinmi,2 Tuoyo O Mene-Afejuku,3 Micheal O Fagbayimu,4 Olusola Fajobi,5 Michael O Balogun6 1Department of Internal Medicine, SCL Healthcare St Vincent’s/Holy Rosary Hospital, Miles city, Montana, 59101, USA; 2Departm
Externí odkaz:
https://doaj.org/article/1ee8a6f1b16541aaba06ea026206deac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Health Research, Vol 1, Iss 2, Pp 86-91 (2015)
Malignant lymphoma, presenting as primary intra-cardiac mass, is rare in children. Without timely intervention, morbidity and mortality may be high in this condition, particularly when it is associated with pericardial effusion and cardiac tamponade.
Externí odkaz:
https://doaj.org/article/fc5f942154704f4396d33b142cba3144
Autor:
Ndakotsu MA, Akinola NO, Adelusola KA, Adejuyigbe EA, Adeodu O, Oyekunle AA, Lawal OO, Bolarinwa RA, Salawu L, Durosinmi MA
Publikováno v:
Infectious Agents and Cancer, Vol 5, Iss Suppl 1, p A3 (2010)
Externí odkaz:
https://doaj.org/article/5b18e83f978a45b3b3870c605d1f495a
Autor:
Aneke, JC, Adegoke, AO, Oyekunle, AA, Osho, PO, Sanusi, AA, Okocha, EC, Okonkwo, KU, Ibeh, NC, Akinola, NO, Durosinmi, MA
Publikováno v:
Orient Journal of Medicine; Vol 26, No 3-4 (2014); 88-93
Background: Sickle cell disease (SCD) has adverse effects on the kidneys which impact on clinical outcome.Objectives: To study and compare some clinical and haematological profiles in SCD patients, with and without chronic kidney disease (CKD).Method
Autor:
R. L. Powles, A Atra, Toon Min, G. J. Swansbury, Daniel Catovsky, Clive Horton, Melissa Dainton, Durosinmi Ma, Estela Matutes, Jennifer Treleaven, K. Rege
Publikováno v:
Leukemia & Lymphoma. 40:67-77
Over a period of 14 years, 50 patients (12 children and 38 adults) of whom 46 had acute myeloid leukemia (AML) and 4 had myelodysplastic syndrome characterized by the t(8;21)(q22;q22) translocation were referred to the Royal Marsden Hospital. The cli
Autor:
Gambacorti Passerini, C, Antolini, L, Piazza, R, Mahon, Fx, Guilhot, F, Deininger, M, Fava, Carmen, Nagler, A, Della Casa CM, Morra, E, Abruzzese, E, D’Emilio, A, Stagno, F, le Coutre, P, Monroy, Fh, Santini, V, Martino, B, Pane, F, Piccin, A, Giraldo, P, Assouline, S, Durosinmi, Ma, Leeksma, O, Pogliani, Em, Pavesi, F, Cecchetti, C, Altieri, C, Rizzo, C, Dilda, I, Mori, S, Kim, Dw, Valsecchi, M. G.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______970::eed97ec86b079b361787cd6a2baf503f
http://hdl.handle.net/2318/157361
http://hdl.handle.net/2318/157361
Autor:
Emmanuel, JD, Durosinmi, MA
Publikováno v:
Nigerian Journal of Clinical Practice; Vol 11, No 3 (2008); 246-249
Objective: To attempt to explain the non-reversal, contrary to the widely held view, of the neurological deficits complicating chronic myeloid leukaemia. Method: Using patients\' case folders and haematological malignancy register all cases of chroni
Autor:
VA Adetiloye, Olusegun Adekanle, Dennis A Ndububa, O S Ojo, Durosinmi Ma, BJ Olasode, O C Famurewa, AO Aladegbaiye
Publikováno v:
West African Journal of Medicine; Vol 24, No 2 (2005); 107-111
Liver cirrhosis and hepatocellular carcinoma are known sequelae of chronic hepatitis. Early diagnosis and treatment of chronic hepatitis could delay or even abort progression to terminal liver disease.Prospective study of 70 consecutive patients with
Autor:
Durosinmi Ma, L Salawu
Publikováno v:
West African Journal of Medicine; Vol 24, No 1 (2005); 54-57
Background: The objective was to investigate the factors influencing survival of Nigerians with Myelomatosis. Materials and Methods: The pre-therapy clinical and laboratory features of patients managed at the Obafemi Awolowo University Teaching Hospi